Changes of the complement system and rheological indicators after therapy with rheohemapheresis

Bláha, 2008, Léčba hemorheoferézou, Aktual Nefrol, 14, 118 Klingel, 2010, RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration, Ther Apher Dial, 14, 276, 10.1111/j.1744-9987.2010.00807.x Klingel, 2003, Clinical studies to implement rheopheresis for age-related macular degeneration guided by evidence-based-medicine, Transfus Apher Sci, 29, 71, 10.1016/S1473-0502(03)00101-0 Klingel, 2000, Rheopheresis: rheologic, functional, and structural aspects, Ther Apher, 4, 348, 10.1046/j.1526-0968.2000.004005348.x Borberg, 2009, 26 years of LDL-apheresis: a review of experience, Transfus Apher Sci, 41, 49, 10.1016/j.transci.2009.05.013 Borberg, 2006, Rheohaemapheresis of ophthalmological diseases and diseases of the microcirculation, Transfus Apher Sci, 34, 41, 10.1016/j.transci.2005.09.001 Rencová, 2013, Reduction in the drusenoid retinal pigment epithelium detachment area in the dry form of age-related macular degeneration 2.5 years after rheohemapheresis, Acta Ophthalmol, 91, e406, 10.1111/j.1755-3768.2012.02503.x Rencová, 2011, Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form, Acta Ophthalmol, 89, 463, 10.1111/j.1755-3768.2009.01710.x Blaha, 2013, Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration, Atheroscler Suppl, 14, 179, 10.1016/j.atherosclerosissup.2012.10.023 Bláha, 2009, The importance of rheological parameters in the therapy of microcirculatory disorders, Clin Hemorheol Microcirc, 42, 37, 10.3233/CH-2009-1184 Blaha, 2009, Extracorporeal LDL cholesterol elimination (25 years of experience in CZ), Atheroscler Suppl, 10, 17, 10.1016/S1567-5688(09)71804-5 Dršata, 2014, The therapy of sudden sensorial hearing loss with rheohemotherapy (in Czech), J Otorhinolaryngol Foniatr, 63, 163 Troutbeck, 2012, Therapeutic targeting of the complement system in age-related macular degeneration: a review, Clin Exp Ophthalmol, 40, 18, 10.1111/j.1442-9071.2011.02581.x Bernhard, 2014, The role of the complement system in age-related macular degeneration, Dtsch Arztebl Int, 111, 133 Langford-Smith, 2014, Role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?, J Innate Immun, 6, 407, 10.1159/000356513 Wang, 2013, Complement factor B polymorphism (rs641153) and susceptibility to age-related macular degeneration: evidence from published studies, Int J Ophthalmol, 6, 861 de Amorim Garcia Filho, 2014, Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration, Ophthalmic Surg Lasers Imaging Retina, 45, 18, 10.3928/23258160-20131217-01 Studnička, 2013, Long-term outcomes of rheohaemapheresis in the treatment of dry form of age-related macular degeneration, J Ophthalmol, 2013, 135798, 10.1155/2013/135798 Amara, 2010, Molecular intercommunication between the complement and coagulation systems, J Immunol, 185, 5628, 10.4049/jimmunol.0903678 Bora, 2005, Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization, J Immunol, 174, 491, 10.4049/jimmunol.174.1.491 Klein, 2005, Complement factor H polymorphism in age-related macular degeneration, Science, 308, 385, 10.1126/science.1109557 Hageman, 2005, A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci U S A, 102, 7227, 10.1073/pnas.0501536102 Edwards, 2008, Toll-like receptor polymorphisms and age-related macular degeneration, Invest Ophthalmol Vis Sci, 49, 1652, 10.1167/iovs.07-1378 Haines, 2007, Rapid dissection of the genetic risk of age-related macular degeneration: achieving the promise of the genomic era, JAMA, 297, 401, 10.1001/jama.297.4.401 Leung, 2013, Update on current and future novel therapies for dry age-related macular degeneration, Expert Rev Clin Pharmacol, 6, 565, 10.1586/17512433.2013.829645 Schwartz, 2013, Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue, J Clin Apher, 28, 145, 10.1002/jca.21276 Mösges, 2009, Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial, Eur Arch Otorhinolaryngol, 266, 943, 10.1007/s00405-008-0823-5